Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05037500
Title Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

prostate cancer

Therapies

Decitabine and Cedazuridine + Enzalutamide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.